share_log
Reuters ·  May 1 08:03
Cocrystal Pharma Inc: Enrollment Completed in Phase 2a Study With Oral Antiviral Candidate Cc-42344 for Pandemic and Seasonal Influenza
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment